USANA Health Sciences, Inc.

USANA Health Sciences, Inc.

USNA
USANA Health Sciences, Inc.US flagNew York Stock Exchange
21.82
USD
-0.83
- -
402.86MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
25.86
31.29
36.78
41.09
43.59
50.46
48.99
53.93
61.18
51.99
48.14
44.82
50.61
50.4
Basic EPS, GAAP
2.85
3.03
3.79
4.09
2.6
5.36
4.64
5.93
6.01
3.61
3.33
2.2
0.59
0.45
Free Cash Flow per Basic Share
3.27
3.35
3.51
4.26
4.6
5.97
5.09
6.91
5.59
4.87
2.94
2.67
0.47
0.16
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
7.2
6.59
8.6
10.84
11.99
13.98
14.14
18.2
17.77
20.39
23.27
25.12
25.48
25.76
Tangible Book Value per Share
7.2
6.78
9.01
11.2
12.93
14.53
14.1
18.7
17.89
20.03
23.53
15.23
17.24
17.84
Basic Weighted Avg Shares
28
25
25
24
24
24
22
21
19
19
19
19
18
18
Sales/Revenue/Turnover
718
790
918
1,006
1,047
1,189
1,061
1,135
1,186
999
921
855
925
926
Operating Margin (%)
16.25
14.69
15.42
13.78
12.65
15.84
13.78
15.55
14.34
10.78
10.11
7.76
5.5
5.3
Depreciation Expense
9
9
10
13
16
17
23
23
22
21
20
22
40
39
Net Income, GAAP
79
77
95
100
63
126
101
125
117
69
64
42
11
8
Effective Tax Rate (%)
32.22
33.74
33.6
27.8
53.55
34.09
33.2
29.94
31.73
36.15
37.74
44.91
72.36
77.28
Profit Margin (%)
11
9.69
10.31
9.94
5.97
10.61
9.48
10.99
9.82
6.94
6.93
4.92
1.16
0.9
Working Capital
133
82
113
139
199
244
193
257
204
241
299
140
160
177
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
261
230
281
325
363
391
352
442
395
434
497
586
586
595
Return on Invested Capital (%)
33.67
29.24
34.19
31.1
16.87
31.08
24.77
29.19
26.13
15.68
11.88
6.38
2.26
1.83
Return on Capital (%)
47.2
41.87
49.66
41.79
22.6
40.88
31.23
35.42
31.36
18.52
15.01
8.3
1.87
1.4
Return on Common Equity (%)
47.2
41.83
49.66
41.66
22.6
40.87
31.63
36.19
32.03
18.84
15.24
9.1
2.28
1.75

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
20
14
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
18
18
Market Capitalization
516
364
321

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
264
288
294
Cash, Cash Equivalents & STI
145
158
163
Accounts Receivable, Net
- -
- -
10
Inventories
91
103
96
Total Current Liabilities
119
129
117
Payables & Accruals
16
38
16
ST Debt
- -
20
14
Deferred Revenue
- -
11
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.25%
6.36%
-0.01%
Free Cash Flow
-10.93%
-34.33%
-83.26%
Net Income, GAAP
-8.99%
-32.71%
-74.4%
Sales/Revenue/Turnover
0.54%
-3.59%
8.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
228
213
200
214
855
2025
250
236
214
226
925
2026
250
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.86
0.55
0.56
0.24
2.2
2025
0.49
0.52
-0.36
-0.1
0.59
2026
0.38
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Kevin G. Guest
Full Time Employees
1,570
Sector
Consumer Defensive
Industry
Household & Personal Products
Address
3838 West Parkway Boulevard Salt Lake City UT United States of America 84120
IPO Date
Apr 4, 1994
Website
usana.com
Business
USANA Health Sciences, Inc. (NYSE: USNA) develops, manufactures, and markets science-based nutritional supplements, healthy foods, and personal care products sold primarily through a direct-selling network of independent Associates and Preferred Customers worldwide. The company offers core vitamin and mineral supplements under its Essentials and CellSentials lines providing advanced total body nutrition for all age groups from children 13 months onward; targeted Optimizers for cardiovascular, skeletal, digestive, and other specific health needs; low-glycemic USANA Foods including Nutrimeal meal replacement shakes, snack bars, and energy products for macro-nutrition and sustained energy; Celavive skincare systems featuring InCelligence Technology for anti-aging and skin renewal; and active nutrition products for performance and recovery. USANA operates in over 20 markets across Asia Pacific including Greater China, Southeast Asia, North Asia, and India; the Americas; and Europe, with in-house research, development, and manufacturing based in Salt Lake City, Utah, where it was founded in 1992 by Dr. Myron Wentz. In recent developments, USANA completed the acquisition of a 78.8% controlling stake in Hiya Health Products for $205 million in December 2024, adding a direct-to-consumer children's wellness brand with clean-label supplements and projected double-digit sales growth; integrated RiseBar into its healthy foods portfolio with channel expansions and new offerings; launched an enhanced Brand Partner compensation plan and several upgraded products at its Global Convention; and extended its sponsorship partnership with the Jamaica Bobsleigh and Skeleton Federation through additional Olympic cycles.

Company News

APIChatGPT
  • USANA Schedules Second Quarter 2026 Earnings Release and Conference Call

  • Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence

  • 5 Low P/B Stocks That Investors Can Add to Their Portfolio in July

  • Should Value Investors Buy USANA Health Sciences (USNA) Stock?

  • 4 Value Stocks to Buy as Lower Energy Costs Strengthen Market Outlook

  • USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy

  • USANA Celebrates 10 Years of Making the World a Better Place During World Service Week

  • 5 Low Price-to-Book Stocks That Are Worth Buying in June

  • These 4 Low Price-to-Cash Flow Stocks Have Winning Potential

  • Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?

  • USANA Earns Dual Best of State Honors for Product Innovation and Development

  • Kevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month

  • Should Value Investors Buy USANA Health Sciences (USNA) Stock?

  • 4 Top Value Stocks to Buy Now as Wall Street Takes Fresh Notice

  • USNA or SDZNY: Which Is the Better Value Stock Right Now?

  • USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?

  • Should Value Investors Buy USANA Health Sciences (USNA) Stock?

  • USANA's People-First Culture Earns Spot on USA TODAY Top Workplaces List

  • USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call Transcript

  • USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates